Liposomal formulations of Cu,Zn-superoxide dismutase: physico-chemical characterization and activity assessment in an inflammation model
- 1 January 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 43 (1) , 1-8
- https://doi.org/10.1016/s0168-3659(96)01473-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ABC of Rheumatology: RHEUMATOID ARTHRITIS--I: CLINICAL FEATURES AND DIAGNOSISBMJ, 1995
- Liposomes as delivery systems in the prevention and treatment of infectious diseasesPharmacy World & Science, 1995
- Clinical Pharmacokinetics and Delivery of Bovine Superoxide DismutaseClinical Pharmacokinetics, 1995
- Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanismBiochemical Pharmacology, 1994
- Liposomal l-asparaginase: in vitro evaluationInternational Journal of Pharmaceutics, 1993
- Assessment of a Human Recombinant Manganese Superoxide Dismutase in Models of InflammationFree Radical Research Communications, 1993
- Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1992
- Active oxygen species, articular inflammation and cartilage damagePublished by Springer Nature ,1992
- Superoxide dismutase treatment reduces [3H]flunitrazepam affinity in cortex and hippocampus of the ratNeuroscience Letters, 1989
- Liposomes as carriers for anti-inflammatory agentsAdvanced Drug Delivery Reviews, 1989